Amesite Inc - AMST STOCK NEWS

Amesite (NASDAQ: AMST) announces its resilience against recent U.S. trade tariffs due to its domestic operations structure. The company, which develops AI-powered enterprise solutions, maintains a fully remote U.S.-based workforce and operates without dependence on foreign hardware or suppliers.

The new trade policy implements a 10% tariff on most imports and up to 32% on goods from certain countries. Amesite's cloud-native infrastructure and domestic technology base shield it from these tariff impacts.

The company's NurseMagic™ solution demonstrates significant efficiency gains, reducing charting time by 95% while ensuring audit-ready documentation. Amesite reports increasing enterprise-wide adoption across clinical and non-clinical teams, including social workers, administrators, and aides, driving user growth and revenue expansion.

Amesite (NASDAQ: AMST) announced successful early adoption of its non-clinical caregiver tool in NurseMagic™, an AI-driven solution supporting non-clinical healthcare workers. The expansion targets home health care and skilled nursing segments, effectively increasing its enterprise addressable market by 50%, reaching over 1.5 million non-clinical healthcare support workers in the U.S.

Key achievements include:

• Hospice provider contracts growth of over 3,000% in the last three months
• Contract sizes increase of nearly 1,000%
• Implementation of automated purchase process for faster contract expansion

The NurseMagic™ solution aims to reduce management intervention needs while improving documentation, communication, and patient care. The company's proprietary AI infrastructure is HIPAA-compliant and designed for rapid training and accuracy, with plans to introduce new tools in the coming months based on customer engagement and market needs.

Amesite (NASDAQ: AMST) announced significant growth in its NurseMagic™ hospice documentation tool adoption. The AI-driven solution addresses critical documentation challenges for hospice care providers, ensuring proper reimbursements and reducing audit risks.

Key highlights include:

• Deal sizes with hospice providers grew by nearly 1,000% over the last three months
• NurseMagic™ sales increased by over 3,000% in the same period
• The platform now supports entire care teams including nurses, clinical professionals, and non-clinical staff
• Specialized hospice notes feature focuses on capturing patient decline documentation

The expansion comes as the hospice care market, currently valued at $31.21 billion, is projected to reach $39.09 billion by 2030 with a 4.61% CAGR. End-of-life care represents 21% of lifetime healthcare costs, making efficient documentation important for market growth.

Amesite (NASDAQ: AMST) announced significant success with its automated sales flow for NurseMagic™ for Teams, an enterprise solution serving home care, home health care, and hospice businesses. The new purchase system has reduced enterprise sales closing time by over 95%, allowing customers to complete subscriptions within minutes of engagement.

The streamlined process enables healthcare organizations to immediately onboard teams to the AI-powered NurseMagic™ platform, which helps reduce documentation burdens and improve workflow efficiency for nurses and caregivers. Enterprise customers can manage subscriptions, control user access, ensure HIPAA compliance, and easily scale by adding licenses as they grow.

According to Amesite, these market segments represent an addressable market exceeding $360 billion annually with over 50,000 U.S. businesses. The company has already secured customers in three key segments and aims to expand across healthcare verticals, contributing to the industry's projected $600 billion AI transformation opportunity by 2034.

Amesite (NASDAQ:AMST), an AI technology company, will be featured on the NASDAQ Tower in Times Square, celebrating recent business achievements. The company's CEO, Dr. Ann Marie Sastry, will attend a media event highlighting the successful launch of NurseMagic™, their proprietary AI app targeting the $130 billion healthcare sector.

NurseMagic™, designed for nursing professionals and home health care workers, has achieved rapid adoption across all 50 U.S. states and 21 countries. The AI-powered application supports daily patient care tasks and career development, featuring tools for creating nursing notes in multiple formats including SOAP, SOAPIER, Narrative, and ISBAR. The company reports strong customer validation through testimonials from paying customers, demonstrating product market fit.

Amesite Inc. (Nasdaq: AMST), an AI technology company, announces its participation in The Microcap Conference 2025 at the Borgata Hotel Spa & Casino in Atlantic City from January 28-30, 2025. CEO Dr. Ann Marie Sastry will deliver a corporate presentation on January 29 at 2:30 PM ET and conduct one-on-one meetings with investors.

The presentation will focus on recent developments of the company's NurseMagic™ app, an AI-powered mobile application designed for nursing professionals and home health care workers. The app aims to streamline daily tasks, enhance efficiency, improve patient communication, and support career development. Dr. Sastry will also discuss the company's growth strategy and monetization plans in both B2C and B2B markets.

Amesite Inc. (Nasdaq: AMST) has announced the closing of its 'best efforts' underwritten public offering, raising approximately $3.6 million through the sale of 1,201,667 shares of common stock at $3.00 per share. Company officers and directors participated in the offering with subscriptions totaling about $1.26 million.

The offering was jointly managed by Laidlaw & Company (UK) and Craft Capital Management The company plans to utilize the net proceeds for general corporate purposes, capital expenditures, working capital, and general and administrative expenses. The offering was conducted under a previously filed and effective shelf registration statement on Form S-3.

Amesite (Nasdaq: AMST) has announced the pricing of its 'best efforts' underwritten public offering of 1,201,667 shares of common stock at $3.00 per share, aiming to raise approximately $3.6 million. Company officers and directors are participating with subscriptions of about $1.26 million.

The offering is expected to close on January 8, 2025, with Laidlaw & Company and Craft Capital Management acting as joint book-running managers. The net proceeds will be used for general corporate purposes, capital expenditures, working capital, and general and administrative expenses.

The offering is being made pursuant to a shelf registration statement on Form S-3 that was declared effective by the SEC on December 18, 2024.

Amesite Inc (Nasdaq: AMST), an AI technology company focusing on B2C and B2B solutions, has announced plans for a 'best efforts' underwritten public offering of common stock and pre-funded warrants. Laidlaw & Company and Craft Capital Management will serve as joint book-running managers for the offering.

The offering will be conducted under a previously filed and effective shelf registration statement (Form S-3, Registration No. 333-282999) from December 18, 2024. The company plans to use the proceeds for general corporate purposes, capital expenditures, working capital, and administrative expenses.

The final terms, size, and completion of the offering remain subject to market conditions, with no guarantees of completion. A preliminary prospectus supplement and accompanying prospectus will be filed with the SEC.